Related Experiment Videos
Magnesium sulfate as an anticonvulsant in eclampsia
1Department of Obstetrics and Gynaecology, Institute of Obstetrics and Gynaecology, Ameenbagh, Hyderabad, India.
Summary
Magnesium sulfate (MgSO4) effectively controls convulsions in eclampsia and imminent eclampsia, proving to be a crucial anticonvulsant. This study highlights its efficacy in managing these severe pregnancy complications.
Area of Science:
- Obstetrics and Gynecology
- Neurology
- Pharmacology
Background:
- Eclampsia and imminent eclampsia are severe pregnancy complications characterized by seizures.
- Effective anticonvulsant therapy is critical for managing these conditions and improving maternal and fetal outcomes.
Purpose of the Study:
- To evaluate the efficacy of magnesium sulfate (MgSO4) as an anticonvulsant in patients with eclampsia and imminent eclampsia.
Main Methods:
- A retrospective review of 736 patient records (562 eclampsia, 174 imminent eclampsia) from January 1987 to December 1989.
- Management included MgSO4 for convulsions, nifedipine for hypertension, and fetal delivery.
- Monitoring for signs of magnesium toxicity, such as depressed knee jerks.
Main Results:
- Convulsions were controlled in 97% of cases with magnesium sulfate.
- Maternal mortality was 2.4% and perinatal mortality was 36%.
- Magnesium toxicity was negligible with observed precautions; depressed knee jerks were the primary indicator of potential toxicity.
Conclusions:
- Magnesium sulfate is a highly effective anticonvulsant for managing eclampsia and imminent eclampsia.
- Controlling convulsions is paramount in the management of eclampsia.
- While effective, careful monitoring for toxicity is essential.